(Q43618300)

25 November 2017

Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori (English)

1 reference

25 November 2017

0 references

1 reference

8

T P Monath

1 reference

25 November 2017

C K Lee

1

1 reference

25 November 2017

K Soike

2

1 reference

25 November 2017

P Giannasca

3

1 reference

25 November 2017

J Hill

4

1 reference

25 November 2017

R Weltzin

5

1 reference

25 November 2017

H Kleanthous

6

1 reference

25 November 2017

J Blanchard

7

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

25 November 2017

11

1 reference

inferred from page(s)

published in

Vaccine

1 reference

25 November 2017

17

1 reference

25 November 2017

23-24

1 reference

25 November 2017

3072-3082

1 reference

Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Helicobacter pylori reinfection with identical organisms: transmission by the patients' spouses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Development of a mouse model of Helicobacter pylori infection that mimics human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Catalase, a novel antigen for Helicobacter pylori vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Vaccination of gnotobiotic piglets against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Systemic immunization with urease protects mice against Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Intranasal booster vaccination against diphtheria and tetanus in man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900144-9

7 January 2021

10.1016/S0264-410X(99)00144-9

Identifiers

DOI

1 reference

25 November 2017

1 reference